Lead the development of deep learning and computer vision models for MRI, X-ray, CT, and PET medical imaging in clinical trials. Build image processing pipelines, analyze disease progression and treatment response, develop imaging biomarkers, integrate AI into trial workflows, support FDA-compliant endpoints, and present findings to clinical, regulatory, executive, and external stakeholders.

Lead data science initiatives supporting drug development, including patient stratification, biomarker identification, therapeutic hypothesis evaluation, clinical trial optimization, and AI agent development. The role applies machine learning, computational biology, and advanced analytics to biomedical data while collaborating with clinical, research, and engineering teams. Responsibilities also include presenting complex findings to senior stakeholders and contributing to production-oriented AI solutions.

Leads the strategy for scaling data science analyses used in pharmaceutical asset acquisition and diligence. Directs cross-functional Data Science and Engineering teams, determines which one-off analyses should become landscape analyses or durable tools, sets roadmaps, evaluates statistical and technical validity, identifies AI opportunities, and connects scientific findings to business impact, asset valuation, and sourcing decisions.